Cancer (Tumor) Cell Lines
Homo sapiens (Human)
Ovary
Adherent
OVSAHO is a human ovarian carcinoma cell line established from the abdominal metastatic tumor of a 56-year-old female with serous papillary adenocarcinoma. OVSAHO expresses several cytokeratins (CKs) peptides. OVSAHO cells are transplantable in both nude and immune-competent mice for intraperitoneal, subcutaneous, and orthotopic heterotransplantation.
OVSAHO cells and their xenograft models are used as experimental platform for studying high-grade serous adenocarcinoma (HGSOC). HGSOC grows rapidly and spread early to other tissues within the peritoneal cavity, and is therefore regarded as one of the most lethal forms of human ovarian cancer. The OVSAHO cells are used to develop strategies for early diagnosis and to screen potential anticancer agents targeting HGSOC.
DHFR Knockout Jurkat Polyclonal Cells
Cat. No. ARG12808
ABHD12 Knockout NCI-H1299 Polyclonal Cells
Cat. No. ARG30178
ART1 Knockout 786O Polyclonal Cells
Cat. No. ARG35710
DNAJC16 Knockout NCI-H1299 Polyclonal Cells
Cat. No. ARG39228
FNBP1 Knockout A549 Polyclonal Cells
Cat. No. ARG10045
MEM Non-Essential Amino Acids (NEAA) Solution (100X)
Cat. No. ARM0992
Complete description is available upon request.